Sartorius AG Pref SRT3

Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Upstream Bioprocessing Equipment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global upstream bioprocessing equipment market is projected to grow rapidly as biopharmaceutical manufacturers expand production capacity and adopt more flexible, efficient manufacturing technologies. The market is expected to increase from $11.13 billion in 2025 to $12.32 billion in 2026, representing a compound annual growth rate (CAGR) of 10.

Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Human Plasma Like Medium Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global human plasma-like medium market is experiencing strong growth as biomedical research organizations, biopharmaceutical companies, and healthcare laboratories seek more physiologically relevant cell culture environments. The market is projected to increase from $0.91 billion in 2025 to $0.99 billion in 2026, representing a compound annual growth ra

Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Nano Bioreactor Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global nano bioreactor market is experiencing rapid growth, driven by expanding biotechnology research, increased adoption of microfluidic bioprocessing, and demand for highly controlled, small-scale cell culture systems. The market is projected to grow from $4.64 billion in 2025 to $5.21 billion in 2026, representing a compound annual growth rate (CAGR) of 12.3

Sartorius has delivered a positive 1 year share price gain alongside fresh attention on bioprocess automation, which puts a sharper spotlight on whether the current valuation lines up with the cash flows investors can reasonably expect from the business. With the stock last closing at €261.00, the key question is how that price compares with an intrinsic value estimate built from its own cash generation. Over 5 years the share price has fallen 52.8%, which makes the gap between past investor...

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director Oxford, UK – 16 October 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Dr Joachim Kreuzburg as an Independent Non-Executive Director, effective on 23 November 2026. Dr Kreuzburg has more than 20 years of public company leadership experience in the global life sciences industry. He was Chair of the Executive Board and Chief Executive Officer of Sartorius A

Boost ROI with modular, customized systems that scale flexibly, cut cleaning and contamination costs, speed fill-finish, and localize sourcing to reduce tariff and supply-chain risks.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Single-Use Assemblies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global single-use assemblies market is experiencing rapid growth, driven by expanding biopharmaceutical manufacturing, increased investment in life sciences research and devel

Boost ROI with scalable, high-throughput 3D platforms that cut variability and per-sample costs, maximize limited cells, and localize production to offset tariffs.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "3D Cell Culture Technologies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global 3D cell culture technologies market is experiencing rapid expansion, supported by growing pharmaceutical research, increased investment in regenerative medicine, and demand for more

Boost ROI via automation, contamination control, premium consumables, targeted R&D, strategic acquisitions and localized manufacturing to offset tariffs.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Consumables and Equipment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell culture consumables and equipment market is experiencing strong growth as pharmaceutical, biotechnology and academic research organizations expand their work in biologics, vacc

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell culture market is experiencing strong growth, supported by expanding life sciences research, increased academic funding and continued development across the biopharmaceutical industry. The market is projected to rise from $31.25 billion in 2025 to $33.81 billion in 2026, representing a compound annual growth rate (CAGR) of 8.2%. Established use of cell

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Continuous Bioprocessing Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global continuous bioprocessing market is experiencing exponential growth as biopharmaceutical manufacturers invest in more efficient, scalable and automated production technologies. The market is projected to increase from $0.38 billion in 2025 to $0.46 billion in 2026, representing a compound annual growth rate (CAGR) of 21.9%. Historical marke

Boost ROI via partnerships, process intensification, single-use systems, modular bioreactors, efficient purification and capacity expansionDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Industrial Bioprocessing Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global industrial bioprocessing market is experiencing strong growth as pharmaceutical manufacturers, biotechnology companies and industrial producers invest in scalable, efficient and sustainable production t

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioprocessing Monitoring Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioprocessing monitoring market is experiencing rapid growth as pharmaceutical manufacturers, biotechnology companies and research laboratories increase their use of real-time process control technologies. The market is projected to grow from $11.55 billion in 2025 to $12.75 billion in 2026, representing a compound annual growth rate (CAGR

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioprocessing Supplies Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioprocessing supplies market is experiencing steady growth as pharmaceutical and biotechnology manufacturers increase production capacity for biologics, biosimilars, vaccines, and other advanced therapies. The market is projected to grow from $10.31 billion in 2025 to $10.73 billion in 2026, representing a compound annual growth rate (CAGR)

Boost ROI with AI/ML controls, biosensing, closed-loop processing, DCS, sensors, perfusion, single-use systems, emerging-market expansion and modular pricing.Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "Bioprocess Automation Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering. The global bioprocess automation market is experiencing strong growth as biopharmaceutical manufacturers increasingly adopt advanced process control technologies to improve

Fresh attention on Sartorius (XTRA:SRT3) comes after a 281 page Research and Markets study on cell based assays named the group among 54 profiled life science suppliers. The latest share price of €260.0 comes after a 30 day share price return of 11.25% and a year to date share price return of 4.92%. The 1 year total shareholder return of 20.17% contrasts with a 5 year total shareholder return that declined 49.45%, suggesting recent momentum in Sartorius is building after a tougher multi year...